设为首页 |  加入收藏
首页期刊介绍编委会投稿须知通知公告刊登文章继续教育园地协办单位联系我们广告合作
公告栏:
萆薢分清丸联合盐酸安妥沙星片治疗ⅢA型前列腺炎的疗效观察
作者:张玉艳  王焕丽  陈倩梅  龙惠  黄久遂 
单位:广州市皮肤病防治所药剂科, 广东 广州 510095
关键词:萆薢分清丸 盐酸安妥沙星片 ⅢA型前列腺炎 临床观察 
中图分类号:R969.4
文献标志码:
出版年,卷(期):页码:2018,28(1):50-52,
收稿日期:2017-10-16
摘要:
目的 探讨萆薢分清丸联合盐酸安妥沙星片治疗ⅢA型前列腺炎的临床疗效。方法 将150例ⅢA型前列腺炎患者随机分为A组、B组及C组各50例,A组单独给予萆薢分清丸每次6 g,1天2次;B组单独给予盐酸安妥沙星片,首日剂量0.4 g,以后每日0.2 g,1天1次,C组给予口服萆薢分清丸每次6 g,1天2次,盐酸安妥沙星片首日剂量0.4 g,以后每日0.2 g,1天1次,3组均在治疗4周后评估疗效。结果 A组、B组及C组总的治疗有效率分别为76.00%、78.00%和94.00%,C组与A组或B组比较差异有统计学意义(P<0.05);治疗后3组慢性前列腺炎症状评分较治疗前显著减少,但C组较A、B两组减少更加明显,组间比较差异有统计学意义(P<0.05);治疗后3组前列腺液中的白细胞数量均较治疗前明显减少,C组较A、B两组减少更加明显,组间比较差异有统计学意义(P<0.05)。结论 萆薢分清丸联合盐酸安妥沙星片治疗ⅢA型前列腺炎疗效显著,值得临床推广应用。
OBJECTIVE To observe the efficacy of Bixiefenqing pills combined with antofloxacin hydrochloride tablets on treatmentof ⅢA prostatitis. METHODS 150 patients with ⅢA prostatitis were randomly divided into three groups, with each group 50 cases. The patients in group A was po administered with only Bixiefenqing pills,6 g per time, twice daily. Group B was po administered with only 0.2 g antofloxacin hydrochloride tablet per day (the first dose double). Group C were po administered with Bixiefenqing pills,6 g per time, twice daily, combined with 0.2 g antofloxacin hydrochloride tablet per day (the first dose double). All the patients in three groups were treated for four weeks, and the efficacy of treatment was evaluated. RESULTS The total effective rate after treatment in group C was 94.00%, which was significant higher than group A (76.00%) or group B (78.00%) (P<0.05, respectively). NIP-CPSI in all three groups were improved with a significant improvement in group C than those of patients in group A or B (P<0.05, respectively). After treatment, EPS white blood cells in three groups were significantly reduced, which was obviously lower in group Cthan those in group A or B (P<0.05, respectively). CONCLUSION A good clinical effect on the treatment of ⅢA prostatitis is achieved by Bixiefenqing pills combined with antofloxacin hydrochloride tablets, which is worth clinical promotion.
基金项目:
广州市科技计划项目(201709010129)
作者简介:
张玉艳,主管药师,Tel:13660784753,E-mail:298088392@qq.com
通讯作者:
参考文献:
[1] 刘骋,梁朝朝,郝宗耀,等.慢性前列腺炎病原菌及药敏分析[J].中国男科杂志,2006,20(4):20-22.
[2] 李奋勇,李威武. 联合药物治疗慢性前列腺炎的疗效观察[J].宁夏医学杂志,2007,29(11):992-993.
[3] 张兆福,梁朝朝,葛魏巍,等.前列腺炎样症状对患者生活质量的影响[J].安徽医学,2009,30(1):2-5.
[4] 李章,高镇松. 慢性前列腺炎患者的血液流变学实验研究[J].中国血液流变学杂志,2004,14(2):189-220.
[5] 翟亚春.非细菌性前列腺炎中医证治研究[J].江苏中医,2001,22(9):9-12.
[6] 郭应禄,胡礼泉.男科学[M].北京:人民卫生出版社,2004:1486-1457.
[7] 梅友健. 新型高效广谱抗菌药物-安妥沙星[J].安徽医药,2010,14(2):229-231.
[8] 肖永红,崔洪,薛峰,等.盐酸安妥沙星片与左氧氟沙星片双盲双模拟随机对照治疗急性细菌性感染临床研究[J].中华内科杂志,2011,50(3):225-229.
[9] 周智恒.现代中医药应用与研究大全-男科学[M].上海:上海中医药大学出版社,1995:134-148.
[10] 周智恒,郁超,陈磊,等.萆薢分清丸治疗慢性前列腺炎110例临床效果观察[J].中成药,2007,29(7):附25-附27.
[11] 杨迎.萆薢分清丸联合乳酸左氧氟沙星治疗急性下尿路感染的疗效观察[J].现代药物与临床,2015,30(4):436-440.
[12] 徐景军,肖飞.萆薢分清丸联合左氧氟沙星治疗ⅢA型前列腺炎临床观察[J].中国医刊,2013,48(8):87-89.
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
 
友情链接  
广东今日药学杂志社有限公司   地址:广州市东风东路753号东塔7楼702
电话:020-37886325       邮箱:jinriyaoxue@163.com
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
粤ICP备20054928号

粤公网安备 44010402002138号

您是第 187158 位访问者